genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Anti cancer drugs

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound
Cancer

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound

Spatial Omics: Improved Therapies for Head and Neck Carcinomas
Multimedia

Spatial Omics: Improved Therapies for Head and Neck Carcinomas

Nano-Immunotherapy Delivers Checkpoint Inhibition And Anticancer Drug to Lung Tumors in Mice
Cancer

Nano-Immunotherapy Delivers Checkpoint Inhibition And Anticancer Drug to Lung Tumors in Mice

Ultrasound Microbubbles Aid Delivery of Chemotherapy and Immunotherapy in Glioblastoma Patients
Cancer

Ultrasound Microbubbles Aid Delivery of Chemotherapy and Immunotherapy in Glioblastoma Patients

Tumor-Targeting, Drug-Loaded Extracellular Vesicles Improve Survival in Cancer-Bearing Mice
Cancer

Tumor-Targeting, Drug-Loaded Extracellular Vesicles Improve Survival in Cancer-Bearing Mice

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives
Cancer

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives

Atherosclerosis Has Tumor-Like Features, May Be Countered by Anticancer Drugs
News

Atherosclerosis Has Tumor-Like Features, May Be Countered by Anticancer Drugs

Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cells
News

Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cells

Targets for Novel Cancer Immunotherapies Identified by Antibiotics
Cancer

Targets for Novel Cancer Immunotherapies Identified by Antibiotics

123...79Page 1 of 79

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up